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Idiopathic IgA nephropathy with segmental necrotizing lesions Segmental necrotizing glomerular lesions usually with
of the capillary wall. concomitant extracapillary proliferation, now univer-
Background. Segmental glomerular necrosis has been de- sally considered to be the marker of a vasculitic damage
scribed in the biopsy material in a minority of patients with
of the glomerular capillary wall, are a rather frequentidiopathic IgA nephropathy in the oldest studies on this disease,
finding in the acute flareups of Henoch-Scho¨nlein pur-but this marker of active capillaritis has received little attention
pura, but are considered a very rare finding in idiopathicin the subsequent literature, and its significance and relevance
for the clinical outcome is still unknown. IgA nephropathy (IgAN). Their presence in a small num-
Methods. Thirty-five out of 340 patients (10.3%) biopsied ber of patients with this disease had been reported in
in our division at the San Carlo Hospital since 1974 showed some older studies on biopsy material [1–9]. However,active segmental necrotizing lesions. The morphological fea-
none of the subsequent numerous studies on large seriestures and the natural history of this group of patients were
of patients, including our oldest studies, have focusedcompared with those of a control group of 229 patients who
had comparable serum creatinine and extent of glomerular attention on the presence of these necrotizing lesions
sclerosis, but who lacked active segmental necrosis. and on their prognostic role in idiopathic IgAN [10–31].
Results. Patients with the necrotic variant showed a signifi- All of these classifications of the morphologic glomer-
cantly more marked extracapillary proliferation and interstitial ular lesions that have been used to predict the prognosisaccumulation of monocytes and T lymphocytes and, in the
were founded either on the separate analysis of singlesegmental areas of necrotizing and extracapillary lesions, infil-
histologic features that did not include segmental necro-tration of monocytes, deposition of fibrinogen, and expression
of the adhesion molecule vascular cell adhesion molecule-1. sis of the capillary loops, or on a grading system based
No difference was found in the presenting clinical syndrome. on the extent and severity of the overall renal lesions,
The clinical course was frequently characterized by acute usually derived from that proposed in 1982 by Lee et al
flareups, and the progression to end-stage renal failure was
[31], in which glomerular necrosis was not consideredmore frequent, although actuarial renal survival was not sig-
among the characterizing features. Extracapillary prolif-nificantly worse (P 5 0.07). The aggressive treatment with
erative lesions, usually present as nonwidespread noncir-steroids and cyclophosphamide, carried out in 20 of the 35
patients, has probably been beneficial, justifying the multicen- cumferential crescents frequently associated with glom-
ter controlled trial that recently has been initiated. erulocapsular adhesion, have been reported in all of the
Conclusions. Vasculitic lesions of the glomerular capillaries, previously cited studies in variable percentages of cases,
with histologic and immunohistological features similar to
and in a few patients a more typical crescentic glomerulo-those of Henoch-Scho¨nlein purpura and antineutrophil cyto-
nephritis, with almost generalized involvement of all glo-plasmic antibody-positive renal vasculitis, were found in 10%
of patients with idiopathic IgAN. Clinical features at presenta- meruli, has been described [32, 33]. However, even when
tion did not differ from those of the other patients with IgAN, extracapillary proliferation was consistent, its presence
and despite of the more frequent occurrences of recurrent was never considered a possible marker of intracapillary
acute flareups, rapid progression to end-stage renal failure was vasculitis, despite the established evidence of the rela-a rare phenomenon, even in untreated patients.
tionship between capillaritis and crescents in both anti-
neutrophil cytoplasmic antibody (ANCA)-positive vas-
culitis and Henoch-Scho¨nlein purpura.Key words: glomerulonephritis, necrosis, Berger disease, active capil-
laritis, vasculitic damage, endothelium injury. At the 1993 International Congress on IgAN in Ade-
laide, our group brought attention to the possible role ofReceived for publication October 22, 1999
segmental glomerular necrosis as a variant of the diseaseand in revised form August 3, 2000
Accepted for publication August 9, 2000 [34]. In Japan, Shouno et al reported that by increasing
the number of serial sections examined for any singleÓ 2001 by the International Society of Nephrology
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biopsy specimen from the usual 20 to 100 in 128 patients arbitrarily selected only the 229 with a serum creatinine
with IgAN, the incidence of the segmental necrotizing #3.5 mg/dL and a percentage of obsolescent glomeruli
lesion increased from 7% (which is similar to that re- #50% at the time of biopsy.
ported by previous investigators) to as much as 30%, Frozen biopsy tissue for the specific immunohistologi-
suggesting that this lesion is probably more frequent than cal studies with monoclonal antibodies was available for
previously believed [35]. only 26 of the 35 patients with necrotizing lesions whose
In the present study, we retrospectively reviewed the histologic material was obtained and processed in the
histologic material of all of our patients with idiopathic last 10 years. As a control population to evaluate these
IgAN, and analyzed the morphological features and the immunohistological features, we selected 28 patients
natural history of the subgroup of patients who at biopsy without necrotizing lesions who were consecutively biop-
showed active segmental necrotizing lesions. In our opin- sied during the same period of time and seven cadaver
ion, an accurate study of this subgroup and a comparison donors whose kidneys could not be grafted because of
with the remaining patients are amply justified by the vascular abnormalities.
recognition that the occurrence of capillaritic lesions in
idiopathic IgAN points to a direct injury of the endothe- Histologic methods
lium of the glomerular capillaries, added to the more
Kidney tissue was obtained in all patients from routineusual injury of the mesangial cells given by the abnormal
biopsies. All specimens were processed routinely forcirculating polymeric IgA1.
light microscopy by the standard method. For each
biopsy specimen, the degree of mesangial proliferation,
METHODS global and segmental glomerular sclerosis, and intersti-
tial fibrosis (graded from 0 to 111) were evaluatedPatients
independently by two investigators, as previously de-From a review of our files, all cases of IgAN that had
scribed [36].been observed and biopsied in our division from 1974
and met each of the following criteria were identified: (1)
Immunoperoxidase labelinglight microscopy slides available for review containing a
For immunoperoxidase labeling, we used an avidin-minimum of six glomeruli; (2) immunofluorescence (IF)
biotin technique in which a biotinylated secondary anti-studies showing the prevalent mesangial deposition of
body reacts with several peroxidase-conjugated streptav-IgA; and (3) no signs of systemic involvement reminis-
cent of Henoch-Scho¨nlein purpura, systemic lupus ery- idin molecules.
thematosus, or chronic liver disease, either at the time of Briefly, after incubation with 0.5% avidin (Sigma Chi-
the biopsy or during the complete course of the disease, mica, Gallarate, Milan, Italy) and 0.01% biotin (Sigma)
before or after the biopsy. to suppress endogenous avidin-binding activity, tissue
Three hundred forty patients met all of these criteria. sections were fixed in a methanol-H2O2 solution (to block
For each of these cases, the case folder, including all of endogenous peroxidase) and then incubated with the
the follow-up observations, and all available microscopic primary antibody. The specificities of anti-human mono-
slides were reviewed (P.N. and F.F.) to select the histo- clonal antibodies used were as follows: CD45, mouse
logic subset characterized by the presence, at least in one anti-human leukocyte common antigen (Dako, S.p.A.,
glomerulus, of segmental glomerular necrosis, defined as Milan, Italy); CD3, rabbit anti-human T lymphocyte
a segmental destructive lesion of the capillary loop, with (Dako); CD68, mouse anti-human monocyte/macro-
fibrin deposition within and around the capillaries, usu- phage (Dako); CD54, mouse anti-human intercellular
ally surrounded by segmental areas of extracapillary pro-
adhesion molecule-1 (ICAM-1; Serotec, Oxford, UK);
liferation. Of the 340 cases, 35 (10.3%) showed these
CD106, mouse anti-human vascular cell adhesion mole-features and represent the cohort of patients included
cule-1 (VCAM-1; Serotec). After washing, the sectionsin this study. In 33 of them, segmental glomerular necro-
were sequentially incubated with the secondary biotinyl-sis was found in the first biopsy, while in the remaining
ated antibody (Dako) and with the peroxidase-labeledtwo, a repeat biopsy, carried out because of an unfavor-
streptavidin (Dako). Peroxidase activity was detectedable clinical course, revealed the presence of the pre-
with 3,5-diaminobenzidine (DAB; Dako); sections wereviously described characterizing histologic features that
then counterstained with Harry’s hematoxylin (BDH,were absent at the first biopsy.
Poole, UK), dehydrated, and mounted in EntellanSince none of these 35 patients had a serum creatinine
(Merck, Darmstadt, Germany).higher than 3.5 mg/dL and a global glomerular sclerosis
Specificity of labeling was proved by the lack of stain-in more than 50% of glomeruli at the time of the biopsy,
ing after substitution of phosphate-buffered saline (PBS)to compare the morphological and clinical features
among the 305 patients without necrotizing lesions, we for the primary antibody.
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Evaluations of immunostained sections RESULTS
Histological and immunohistological featuresImmunostained sections, which contained at least six
glomeruli, were evaluated independently by two investi- As previously indicated, the characterizing feature in
gators without any clinical and pathological information, all the 35 patients selected for the study was the presence,
as previously described [37]. at least in one glomerulus, of segmental glomerular ne-
crosis, defined as a destructive lesion of the capillaryIntraglomerular-labeled cells were counted and ex-
loop, with fibrin deposition within and around the capil-pressed as mean cells 6 SD per glomerular cross section,
laries (Fig. 1A). The necrotizing lesions involved a vari-and cells within crescents were included in glomerular
able percentage of glomeruli ranging from 3 to 25%counts.
(mean 8.6), and were usually associated with adjacentLabeled interstitial cells were counted in a sequence of
segmental areas of extracapillary cellular proliferation10 consecutive 3400 high-power fields using an eyepiece
and also frequently with adhesions of the glomerular tuftgraticule (Periplan 6F 12.5 3 MF mounted in a Leitz
to Bowman’s capsule (Fig. 1A). As indicated in Table 1,Dialux 20 microscope; Wetzlar, Germany), avoiding glo-
this extracapillary proliferation involved a percentagemeruli, large vessels and focal infiltrates. The results
of glomeruli ranging between 8 and 53% (mean 24.5),were expressed as mean cells 6 SD/mm2.
significantly more marked than in the control population
Periglomerular infiltrates were evaluated separately
with IgAN and absence of glomerular necrotizing lesions
with a semiquantitative method (grading from 0 to 11). (mean 4.5). In this latter population, extracapillary pro-
Intraglomerular and tubular staining for adhesion liferation that was frequently fibrocellular or fibrotic was
molecules was scored semiquantitatively using a four- present in 29% of the 229 patients, and in only 13 of
point score: 0 5 no staining; 1 5 focal staining; 11 5 them it involved more than 10% of glomeruli (10 to 37%).
diffuse staining; 111 5 massive staining. Another characterizing feature by light microscopy
was the presence of interstitial infiltration of diffuse
Antineutrophil cytoplasmic antibodies and/or segmental leukocytes, frequently with a periglom-
erular accentuation (Fig. 1A). As shown in Table 1, bothTwenty-two of the 35 patients were measured both by
focal and diffuse interstitial infiltration were found inindirect immunofluorescence (IF) and by enzyme-linked
a significantly higher number of biopsy specimens inimmunosorbent assay (ELISA) according to the stan-
comparison with the control population of patients withdardized procedures already described [38, 39].
IgAN and absence of necrotizing lesions, while the extent
of glomerular sclerosis and interstitial fibrosis did notStatistical methods
differ in the two groups of patients.
Results are expressed as mean value 6 SD. The small-
By IF, there was no difference in the frequency and in-
est and the largest values are reported for frequency tensity of deposition of IgA and IgG (Fig. 1B), and IgM,
data. Data were analyzed by two-tailed Student t test nor in the incidence of the combined mesangial and capil-
for paired or unpaired data when required. Differences lary staining for IgA between patients with and without
among proportions were tested using chi-square test. necrotizing lesion (Table 1). However, segmental areas
Survival curves were constructed according to the of fibrinogen deposition were present in only the sub-
Kaplan–Meier method, and the log-rank test was applied group of patients with necrotizing lesions (Fig. 1C).
to determine survival. P values #0.05 were considered
Immunochemical featuressignificant. Statistical analyses were performed using sta-
tistical procedures of SAS system, version 6.04 (SAS Table 2 summarizes the results of the immunoperoxi-
dase labeling of infiltrating cells in the glomeruli and inInstitute, Cary, NC, USA).
c
Fig. 1. (A) The glomerulus shows a segmental area of tuft necrosis associated with a small cellular crescent. A periglomerular leukocyte infiltration
is also present (Trichrome; 3250). (B) Immunofluorescence. Deposits of IgA located mainly in the mesangial stalk region (anti-IgA antiserum;
3250). (C ) Immunofluorescence. Fibrinogen is strongly positive only in well-delineated areas of the glomerular tuft, corresponding to areas of
segmental intracapillary necrosis seen at light microscopy (antifibrinogen antiserum; 3250). (D) The glomerulus shows monocyte infiltration
restricted to a segmental area of the tuft (immunoperoxidase conjugated anti-CD68 antibody; 3250). (E ) Intense periglomerular leukocyte
infiltration in a patient with necrotizing lesions is evident (immunoperoxidase-conjugated anti-CD45 antibody; 3250). (F ) Strong positivity of
adhesion molecule VCAM-1 is present in segmental area of the glomerular tuft corresponding to necrotizing crescentic lesion seen by light
microscopy (immunoperoxidase conjugated anti–VCAM-1 antibody; 3250). (G) The adhesion molecule ICAM-1 is significantly overexpressed
and extended to the whole mesangial area in a glomerulus from a patient with IgAN. (H ) In a repeat biopsy, a well-delineated segmental area
of glomerular sclerosis with Bowman’s capsule adhesion is present, as a consequence of previous (first biopsy) localized necrotizing-extracapillary
lesion (Trichrome; 3250).
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Table 1. Histological and immunohistological lesions in 35 patients with necrotizing IgAN and in 229 patients with non-necrotizing IgAN
Necrotizing IgAN Non-necrotizing IgAN P
Number of patients 35 229
Extracapillary proliferationa 24.5% (8–53) 4.5% (0–37) ,0.01
Segmental glomerulosclerosisa 5.2% (0–25) 7.3% (0–57) NS
Global glomerular sclerosisa 15.8% (0–40) 9.5% (0–44) NS
Marked mesangial proliferationb 40% 36% NS
Marked interstitial infiltrationb 86% 8% ,0.01
Marked interstitial fibrosisb 23% 24% NS
Combined mesangial and capillary
deposition of IgA by IFb 43% 54% NS
a % of glomeruli (mean and range)
b % of biopsies
Table 2. Glomerular and interstitial expression of markers of leukocyte infiltration in patients with necrotizing IgAN
and non-necrotizing IgAN
Normal controls Non-necrotizing IgAN Necrotizing IgAN
Number of individuals 7 28 26
Glomerular expression
N of cells/glomerular cross section
Total leukocytes (CD 45) 1.960.4 2.060.8 ˆa! 5.061.2
Monocytes (CD 68) 0.860.4 0.660.7 ˆa! 3.261.7
T-lymphocytes (CD 3) 0.660.2 0.360.3 1.360.7
Interstitial expression N of cells/mm2
Total leukocytes (CD 45) 72653 119675 ˆa! 2436143
Monocytes (CD 68) 43630 44653 ˆa! 8065
T-lymphocytes (CD 3) 28623 ˆa! 84668 ˆa! 1456101
a P , 0.01
the interstitium of the fresh frozen biopsy material taken number of T lymphocytes was significantly higher (Table
from 26 patients with segmental necrotizing IgAN com- 2). All infiltrating interstitial cells were significantly more
pared with that obtained from 28 patients without such numerous in the necrotizing variant of IgAN in compari-
lesions who were consecutively biopsied during the same son with non-necrotizing IgAN. The cells infiltrating the
period of time and with the normal kidney tissue taken interstitium had a prevalent periglomerular localization
from cadaver donors. The two populations of IgAN pa- in two thirds of the patients with necrotizing IgAN (Fig.
tients with and without necrotizing lesions did not differ 1D, E).
in mean age (32 6 12 vs. 35 6 15 years), male:female Table 3 summarizes data on glomerular expression of
ratio (18:8 vs. 21:7), mean serum creatinine levels (1.3 6 adhesion molecules VCAM-1 and ICAM-1. VCAM-1,
0.5 vs. 1.2 6 0.3 mg/dL), and frequency of arterial hyper- which was weakly expressed only on epithelial cells of
tension (42 vs. 43% of patients), while the mean daily Bowman’s capsule in glomeruli from normal kidney tis-
proteinuria was significantly higher in patients with nec- sue and from biopsy tissue of patients with non-necrotiz-
rotizing lesions (2.3 6 2.0 vs. 0.7 6 0.8 g/24 h; P , 0.01). ing IgAN, was intensely expressed in segmental and fo-
The number of total intraglomerular leukocytes (CD451
cal, well-delineated areas of the tuft in some glomeruli
cells), monocytes (CD681 cells), and T lymphocytes
in patients with necrotizing IgAN (Fig. 1F). These areas(CD31 cells) was not significantly higher in patients
corresponded exactly, as site and percentage of glomeruliwith non-necrotizing IgAN than in normal controls. In
involved, to the areas of segmental necrotizing and cres-patients with necrotizing IgAN, the average number of
centic involvement observed with thrichrome staining, asintraglomerular total leukocytes and monocytes was sig-
well as to the areas with monocyte infiltration describednificantly higher than in patients with non-necrotizing
previously in this article.lesions. The cells infiltrating the glomeruli in patients
Intercellular adhesion molecule-1 (which in normalwith necrotizing IgAN were concentrated in segmental
kidneys was expressed only on the endothelial cells ofareas corresponding to the areas of necrosis shown by
the glomerular capillary wall) was significantly overex-traditional stain in the same glomeruli (Fig. 1D). Intersti-
pressed in glomeruli from patients with both types oftial infiltration of total leukocytes and monocytes was
IgAN, extending to the entire mesangial area (Fig. 1G).not significantly more marked in patients with non-nec-
rotizing IgAN than in normal controls, while the average The intensity of this expression was concordant with the
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Table 3. Glomerular expression of adhesion molecules in 26 patients with necrotizing IgAN and in 28 patients with non-necrotizing IgAN
Normal kidneys (N 5 7) Non-necrotizing IgAN (N 5 28) Necrotizing IgAN (N 5 26)
Positivity Glomerular Positivity Glomerular Positivity Glomerular
(1/11/111) localization (1/11/111) localization (1/11/111) localization
ICAM-1 1 Endothelial 11 Endothelial and 111 Endothelial, mesangial and areas of
mesangial necrotizing/extracapillary lesion
VCAM-1 1 Bowman’s 1 Bowman’s 111 Areas of necrotizing/extracapillary
capsule capsule lesion
Table 4. Demographic and clinical features at the time of renalextent of mesangial damage (proliferation and/or matrix
biopsy in 35 patients with necrotizing IgAN and in 229 patientsexpansion). with non-necrotizing IgAN
Non-Repeated biopsies
Necrotizing necrotizing
In 2 of the 35 patients, the histological and immunohis- IgAN IgAN P
tological features described previously in this article were Number of patients 35 229
found upon a repeat biopsy four and five years after the Sex male/female 26/9 147/82 NS
Mean age years 33612.5 32613 NSfirst biopsy, respectively, which were carried out because
Serum creatinine mg/dL 1.360.5 1.260.4 NSof an unfavorable clinical course (increase of proteinuria
Proteinuria g/day 2.362.1 1.161.2 ,0.003
and/or serum creatinine). Features of glomerular seg- History of recurrent macroscopic
hematuria % of patients 20% 31.2% NSmental necrosis were absent at the first biopsy in both
Arterial hypertensioncases. Segmental extracapillary proliferation and intra-
% of patients 37% 41% NS
glomerular infiltration of monocytes were found in both
cases only at the second biopsy, together with a marked
increase of interstitial infiltration of leukocytes, both
monocytes and T lymphocytes. nephrotic range were the only clinical signs at the time
A second biopsy was also carried out in six additional of biopsy in 28 (80%) of the 35 patients with necrotizing
patients from 5 to 17 years after a first biopsy showing lesions. An episode of macroscopic hematuria had oc-
the existence of segmental necrotizing lesions. In one of curred in three (9%) patients, and nephrotic syndrome
them, the new biopsy was performed because after seven was found in one (3%). Two patients had chronic renal
years there was persistent severe proteinuria and a mild failure, and one patient experienced a rapid decline of
impairment of renal function. The biopsy documented renal function.
that the very mild segmental necrotic involvement of Table 4 compares demographic and clinical parame-
the glomerular capillaries was unchanged. Unchanged ters at the time of biopsy in the 35 patients with necrotiz-
as well was the extent of the extracapillary proliferation ing lesions and in 229 patients without necrotizing lesions
and of the intraglomerular monocyte infiltration, while selected as previously indicated. Both groups had a simi-
the interstitial infiltration of total leukocytes and of
lar age and male predominance. Mean serum creatinineT lymphocytes had increased from 129 to 437 mm2 and
levels were not significantly different. Gross hematuriafrom 68 to 368 mm2, respectively. In the remaining five
at the time of biopsy or a previous history of recurrentpatients, the new biopsy was performed in the absence
macroscopic hematuria were reported in similar percent-of clinical signs suggesting an active disease, to document
ages of patients. Frequency of arterial hypertension wasthe fate of the morphological signs of segmental capillary
not significantly different in the two groups. The meannecrosis. In all cases, necrotic lesions were no longer
duration of the prebiopsy follow-up was longer in pa-present, while segmental areas of sclerosis with glomeru-
tients without signs of necrotizing vasculitis than in pa-locapsular synechiae were found (Fig. 1H). Extracapil-
tients with necrotizing lesions: 60 months (range 3 tolary proliferation had also completely disappeared in
240) versus 33 months (range 4 to 191). Only the averagefour of them, while it had increased in the remaining
amount of urinary daily loss of proteins at the time ofpatient. Intraglomerular infiltration of monocytes had
biopsy was significantly different in the two groups ofdecreased in all patients to less than one cell per glomeru-
patients: It was higher in patients with segmental necroticlus, and interstitial infiltration of monocytes and T-lym-
lesions.phocytes was less marked in all patients, while interstitial
Although we searched for IgG ANCAs in 22 of thefibrosis was moderately increased.
35 patients with necrotizing lesions using IF and ELISA,
Clinical features and natural history no patient had them.
The study of the natural history of patients with necro-Asymptomatic urinary abnormalities characterized
by microscopic hematuria and proteinuria in the non- tizing lesions has been complicated by the interfering
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variables of anti-inflammatory and immunosuppressive As shown in Table 5, mean proteinuria was significantly
lower than at the time of biopsy in treated patients, whiletherapies instituted in some of them during the last 10
no significant differences were found in the mean levelsyears, in a nonrandomized fashion, because of some signs
of serum creatinine. Figure 2 illustrates the clinicalof a more progressive course (rapid, usually moderate
course of one treated patient who had received threeincrease of proteinuria, and of serum creatinine). In
courses of treatment over the previous five years, withtreated as well as in nontreated patients, the clinical
a reduction of urinary protein loss and stabilization ofcourse was frequently characterized by recurring epi-
serum creatinine to levels approximately 2 mg/dL.sodes of more acute disease, as indicated by a sudden
A Kaplan–Meier estimate of renal survival in the 229increase in urinary protein loss and slight elevation of
patients without necrotizing lesions selected as the con-
serum creatinine levels. However, no systemic signs of trol group was compared with that of the subgroup of 15
Henoch-Scho¨nlein purpura manifested during the fol- patients with necrotizing IgAN who received treatment
low-up. with steroids and cyclophosphamide and of the subgroup
The treatment was identical to that in use in our unit of 20 patients who did not receive treatment (these pa-
for the patients with rapidly progressive crescentic glo- tients, as those with non-necrotizing IgAN, since 1993
merulonephritis caused by vasculitis. It consisted of ste- have been treated with ACE inhibitors; Fig. 3). Despite
roids (3 intravenous pulses of 0.75 to 1.0 g of methyl- the trend to a more rapid loss of renal function in un-
prednisolone, followed by oral prednisone for 6 months treated patients with necrotizing IgAN, the difference
at progressively tapering doses, starting with 0.5 mg/kg/ in the rate of progression did not reach statistical signifi-
cance (P 5 0.07).day) and cyclophosphamide (2 mg/kg/day for 16 weeks).
It was started in all patients immediately after biopsy.
This specific therapy was added to the usual therapy with DISCUSSION
variable doses of angiotensin-converting enzyme (ACE)
While segmental necrosis of the glomerular tuft usu-
inhibitors, which has been given to all of our patients with ally associated with extracapillary proliferation has al-
IgAN since 1993, including those without necrotizing ways been considered a characterizing histologic lesion
lesions. in the glomerulonephritis of Henoch-Scho¨nlein purpura,
The extent of necrotic involvement and of extracapil- the less frequently documented presence of such a lesion
lary proliferation was comparable in the groups of even in some patients with idiopathic IgAN has received
treated and untreated patients (9 vs. 8.3% of glomeruli much less attention in the last 20 years, after its accurate
and 28.7 vs. 21.4% of glomeruli, respectively), and the description in many of the oldest morphological studies
difference in initial serum creatinine levels was not sig- on this disease [1–9]. This fact is hard to understand if
nificantly different. The duration of postbiopsy follow- one considers that it points to a pathogenetic mechanism
up was quite variable in the different patients with necro- different from that which is universally accepted as pre-
eminent in this disease (that is, the damaging effect oftizing lesions, ranging from 12 to 204 months (mean 63
deposited macromolecular IgA1 on the mesangial cellsmonths). Since immunosuppressive treatment was insti-
[40]) and suggests a concomitant direct injury on thetuted in the more recent years, the duration was shorter
endothelial cells of the glomerular capillary wall, within the 15 treated patients (mean 50.4 months; range 12
its potential disruption that induces extracapillary prolif-to 108 months) than in the 20 untreated patients (mean
eration.74 months; range 12 to 204 months). During this period,
The histological and immunohistological features ofonly one of the treated patients progressed to end-stage
our 35 patients show a strict similarity with the necrotiz-renal failure (ESRF) requiring dialysis, this occurring 48
ing capillaritic lesion described in Henoch-Scho¨nleinmonths after biopsy. By comparison, 7 of the 20 patients
purpura [41] and in ANCA-positive systemic vasculitiswho did not receive immunosuppressive treatment pro-
[42, 43]. Characteristics found in these two diseases were
gressed to ESRF, with a mean interval from the renal (1) a variable degree of extracapillary proliferation, usu-
biopsy of 70.2 months (range 36 to 96 months). However, ally segmental and adjacent to the areas of necrosis;
because of the limited number of patients and of the (2) the intraglomerular influx of infiltrating cells, mainly
different duration of the follow-ups, it was not possible monocytes, restricted to the areas of necrosis; (3) a sig-
to compare renal survival in the two subgroups of pa- nificantly more marked interstitial accumulation of infil-
tients. A comparative analysis of the variations of mean trating cells (both monocytes and T lymphocytes) than
serum creatinine and daily proteinuria levels was per- in non-necrotic IgAN, with a frequent periglomerular
formed on the 20 untreated and the 15 treated patients, accentuation; and (4) the intense deposition of fibrinogen
arbitrarily using one year after biopsy as the end point, in areas of tuft necrosis seen by IF.
Infiltrating glomerular monocytes were a characteriz-since none of the patients had reached ESRF at that time.
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Table 5. Serum creatinine and proteinuria in treated and untreated patients with necrotizing IgAN at the time of biopsy and one year later
Serum creatinine mg/dL Proteinuria g/24 hours
Number of At the time After one At the time After one
patients of biopsya year of biopsya year
Treated patients 15 1.4860.58 1.3860.5 3.2262.82 1.4862.47b
Untreated patients 20 1.2560.43 1.3660.5 1.5761.04 1.5160.9
a Treatment, consisting of steriods and cyclophosphamide, was started in all patients immediately after biopsy
b P 5 0.01
Fig. 2. Flow chart of the values of urinary
protein excretion and serum creatinine in one
patient with necrotizing IgAN receiving three
courses of six months of treatment with steroid
and cyclophosphamide during a follow-up pe-
riod of more than seven years.
ing feature of our subgroup of patients, since we did not et al [46]. Even the more marked accumulation of mono-
cytes and T cells in the interstitium, which we found infind increased numbers of these cells in patients with
non-necrotizing IgAN, including those with intense mes- the necrotizing variant, had been already described by
Li et al in their IgAN patients with crescents [44].angial proliferation. This finding is in agreement with
that of Li et al, who described intraglomerular infiltration The study of ICAM-1 and VCAM-1 expression in the
biopsies of our patients deserves some commentary. Inof monocytes only in patients with “crescentic” IgAN
(the concomitant presence of necrotizing lesions has not eight patients with IgAN and absence of crescents, Brujin
and Dinklo reported an up-regulation of ICAM-1—butbeen looked for by these investigators), but not in those
without extracapillary proliferation [44]. Nagata et al not of VCAM-1—in the mesangial area, similar to that
which we found in our patients, independently of thein early biopsies of pediatric patients found a variable
infiltration of glomerular monocytes/macrophages closely presence of necrotizing lesions [47]. However, in the
segmental areas of necrotizing and extracapillary lesions,associated with endocapillary proliferative lesions and
mesangial proliferation, but also with tuft necrosis, and we also found an abnormal expression of the adhesion
molecule VCAM-1 that we had already described as awith the “sites of formation of small cellular crescents”
[45]. A significant correlation between the extent of in- distinctive marker of the glomerular necrotizing lesions
in ANCA-positive systemic vasculitis [43].traglomerular infiltration of monocytes-macrophages
and degree of extracapillary proliferation in IgAN, with- These data suggest that while ICAM-1 probably plays
a role in the mesangial damage present in all patientsout any mention of the concomitant presence or absence
of necrotizing lesions, has also been reported by Arima with IgAN, VCAM-1 overexpression is the marker of a
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capillary proliferation was sometimes the only sign of
an extracapillary epithelial damage. On the other hand,
we found signs of segmental extracapillary proliferation
even in some of the patients of the group arbitrarily
selected as the control group because of the absence of
signs of active segmental glomerular biopsy in the biopsy
specimen. Considering that in such a control group extra-
capillary proliferation was frequently in a fibrotic stage
and that it was sometimes associated with a mild intra-
glomerular monocyte infiltration of leukocytes, we can-
not rule out the possibility that it represents the indirect
sign of a necrotic lesion, either healed or present in an
active stage in a glomerular area not included in the
Fig. 3. Life-table analysis of renal survival in 229 patients with non- stained section, as suggested by Shouno et al [35]. If
necrotizing IgAN (solid line), in 15 treated (dotted line) and in 20 such is the case and the control group includes cases ofuntreated (dashed line) patients with necrotizing IgAN.
“necrotizing” IgAN without obvious signs of segmental
necrosis in the limited available specimen, the differ-
ences between the two groups of patients compared in
more specific lesion, the segmental necrotizing lesion Tables 1 and 4 become even more significant. Moreover,
present in a limited subgroup of patients with IgAN, it justifies the policy of processing many more additional
either idiopathic or systemic (Henoch-Scho¨nlein pur- sections when the histologic material obtained routinely
pura), and in all patients with ANCA-positive systemic does not show intraglomerular segmental necrosis but
vasculitis. Since no IgG-ANCAs could be detected in documents an extracapillary proliferation exceeding
any of our tested patients with necrotizing lesions, we 20% of glomeruli, especially when conventional staining
hypothesize that the activation of VCAM-1 is the conse- shows marked interstitial infiltration of leukocytes, with
quence of the endothelial inflammatory damage, inde- a periglomerular accentuation.
pendently of the immunologic mechanism responsible At variance with what is found in patients with ANCA-
for the direct injury of the endothelial cells. This negative positive systemic vasculitis, our patients with necrotizing
serum ANCA determination in our tested patients is IgAN showed a marked and diffuse mesangial prolifera-
worth emphasizing in view of the recent description of tion as frequently as in the cohort of patients without
a few cases of rapidly progressive crescentic glomerulo-
necrotizing lesions (Table 1). This suggests that the dam-
nephritis with clinical signs of systemic vasculitis, high
aging effect on the mesangial cell coexists with that di-titers of IgG-antimyeloperoxidase antibodies, and mes-
rectly exerted on the endothelium of the capillary wall.angial deposition of IgA shown by IF [48–50]. As we
Considering that the biopsy revealing active necrotizinghave said, systemic signs were absent at presentation
lesions has been performed in our 35 patients many yearsand during the clinical course in all of our patients with
after the apparent onset [the average interval was 33necrotizing IgAN. We believe that the isolated cases
months (range of 4 to 192)], it can be hypothesized thatdescribed in the recent literature refer to associations
these lesions may occur in a patient with the typicalof IgAN and ANCA-positive systemic vasculitis, while
mesangial pathology in a later stage of the disease, trig-there is agreement that in the absence of such an associa-
gered by some as yet unknown superimposed immuno-tion between two different diseases, IgG-ANCAs are
logic event. This hypothesis is confirmed by the absenceconstantly negative in both idiopathic IgAN and Hen-
of active necrosis in the first biopsy in our two patientsoch-Scho¨nlein purpura [51–53].
who were rebiopsied because of a rather sudden changeIt is important to note that the extracapillary prolifera-
in clinical conditions.tion, although on average more marked than in the con-
The postbiopsy follow-up of our patients as well astrol cohort of patients without active signs of necrosis
the data emerging from rebiopsy in some patients suggest(Table 1), was not widespread and circumferential in our
that the necrotic lesions and the concomitant extracapil-patients with necrotizing lesions; rather, the extracapil-
lary proliferation may heal, leaving segmental areas oflary proliferation was characteristically segmental and
glomerular sclerosis and fibrous crescents, with a clinicallocated in close vicinity to the areas of necrosis in the
course characterized by stages of quiescence (especiallyglomeruli. Frequently, it did not involve more than 10
after treatment) and possible subsequent exacerbationsto 15% of glomeruli and slightly exceeded half of them
(new areas of active segmental necrosis?), similar to thatin only one patient. In other words, necrotizing lesions in
which is frequently documented for the glomerular in-idiopathic IgAN are not always associated with massive
crescent formation, and a mild noncircumferential extra- volvement of ANCA-positive systemic vasculitis. The
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flow chart depicted in Figure 2 illustrates this clinical control population of patients without demonstrable nec-
rotizing lesions. In particular, only one patient exhibitedbehavior.
If we accept the proposed hypothesis that tissue depo- at presentation signs of acute renal failure and another
one a nephrotic syndrome, while recurrent macroscopicsition of an abnormal IgA1 produced by the immunocom-
petent cells is responsible for the morphological lesions hematuria was reported in only 20% of the patients with
necrotizing IgAN versus 31% of patients with non-necro-characterizing both idiopathic IgAN and Henoch-Scho¨n-
lein purpura [40, 54, 55], the difference between these tizing IgAN. Even arterial hypertension was not more
frequent at the time of biopsy in patients with necrotizingtwo diseases being that in Henoch-Scho¨nlein purpura
the damage produced by such deposition is more wide- lesions. In other words, necrotizing IgAN does not have
characterizing clinical features at presentation and canspread, also involving extrarenal tissues, then we can
hypothesize that the spectrum of the lesions inducible be found casually in biopsy specimens taken from pa-
tients with an apparently indolent chronic clinical course.in different patients is a continuum. This continuum has
the lesions restricted to the mesangium at one end and The retrospective analysis of the postbiopsy history sug-
gests that even when only ACE inhibitors are adminis-the lesions involving the mesangium and the wall of
small vessels (to give a systemic vasculitis with cutaneous tered to these patients, a rapidly progressive course is
by no means the rule, although we suspect that chronicpurpura) at the other end, but includes an intermediate
range of lesions, restricted to the kidney but not to the progression to ESRF may occur slightly more rapidly or
frequently than in patients without necrotizing lesions.mesangium, to give a glomerular capillaritis concomitant
with the mesangial lesions. Obviously, if this hypothesis That being said, is the aggressive treatment with ste-
roids and immunosuppressive agents used in other typesis accepted, all of the histologic classifications of IgAN
based on a grading of overall severity of the glomerular of necrotizing capillaritic lesions justified in patients with
necrotizing IgAN nephropathy? Our personal experi-and tubulointerstitial lesions that have been proposed
and used in the last 15 years are inadequate and mis- ence does not allow us to answer this question, although
in some patients with more active clinical signs of acuteleading.
Montinaro et al have recently described a model of disease, such therapeutic approaches appear to have been
beneficial. We have recently undertaken a multicenterIgAN obtained by the passive administration in mice of
IgA/IgA immune complexes [56]. By changing the type controlled trial to define better the efficacy of steroids
plus cyclophosphamide in this variant of IgAN.and amount of antigen to be fixed in situ to such IgA-
immune complexes, they were able to reproduce glomer-
ular lesions ranging from mild mesangial hypercellularity ACKNOWLEDGMENT
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